- Home
- PAYO vs XENE Comparison
PAYO vs XENE Comparison
Compare PAYO & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYO
- XENE
- Stock Information
- Founded
- PAYO 2005
- XENE 1996
- Country
- PAYO United States
- XENE Canada
- Employees
- PAYO N/A
- XENE N/A
- Industry
- PAYO EDP Services
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- PAYO Technology
- XENE Health Care
- Exchange
- PAYO Nasdaq
- XENE Nasdaq
- Market Cap
- PAYO 2.7B
- XENE 2.4B
- IPO Year
- PAYO N/A
- XENE 2014
- Fundamental
- Price
- PAYO $6.69
- XENE $38.14
- Analyst Decision
- PAYO Strong Buy
- XENE Strong Buy
- Analyst Count
- PAYO 8
- XENE 10
- Target Price
- PAYO $10.06
- XENE $53.20
- AVG Volume (30 Days)
- PAYO 3.6M
- XENE 1.0M
- Earning Date
- PAYO 08-06-2025
- XENE 08-11-2025
- Dividend Yield
- PAYO N/A
- XENE N/A
- EPS Growth
- PAYO N/A
- XENE N/A
- EPS
- PAYO 0.25
- XENE N/A
- Revenue
- PAYO $1,017,244,000.00
- XENE $7,500,000.00
- Revenue This Year
- PAYO $4.94
- XENE N/A
- Revenue Next Year
- PAYO $5.85
- XENE $253.71
- P/E Ratio
- PAYO $26.64
- XENE N/A
- Revenue Growth
- PAYO 13.02
- XENE N/A
- 52 Week Low
- PAYO $5.71
- XENE $26.74
- 52 Week High
- PAYO $11.29
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- PAYO 48.87
- XENE 70.65
- Support Level
- PAYO $6.59
- XENE $32.78
- Resistance Level
- PAYO $6.90
- XENE $38.05
- Average True Range (ATR)
- PAYO 0.26
- XENE 1.55
- MACD
- PAYO 0.01
- XENE 0.62
- Stochastic Oscillator
- PAYO 32.99
- XENE 88.44
About PAYO Payoneer Global Inc.
Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.